Medical Technologies
Indian NGOs confront GWU Law School efforts to push maximalist IPR norms in India
Submitted by Judit Rius on 4. March 2010 - 17:10The ties between Universities and businesses are often complex and blurred. Private companies or trade associations fund research and seminars, and have consulting relationships with faculty members, trying to shape public policy and judicial decisions on a wide range of issues. A particularly interesting industry/university connection concerns something called the "India Project," that is associated with the George Washington University (GWU) Law School.
March 28, 2001 Letter to US Secretary of Health and Human Services Tommy Thompson regarding access to NIH funded patents
March 28, 2001
Secretary Tommy Thompson
Department of Health and Human Services
200 Independence Avenue, SW
Washington, DC 20201
Dear Mr. Thompson:
September 1999 Letter to NIH, urging it provide the World Health Organization with access to U.S. government-funded medical inventions
Submitted by James Love on 17. September 2009 - 6:21Ralph Nader
P.O. Box 19312, Washington, DC 20036
James Love
Consumer Project on Technology
P.O. Box 19367, Washington, DC 20036
http://www.cptech.org
Robert Weissman
Essential Action
P.O. Box 19405, Washington, DC 20036
http://www.essentialaction.org/
September 3, 1999
Dr. Harold E. Varmus
Building 1, 126
National Institutes of Health
Bethesda, Maryland 20892
Congressional Hearings in 110th U.S. Congress, on pharmaceutical drugs (including trade issues)
U.S. Senate
Appropriations Committee
Subcommittee on Labor, Health and Human Services, and Education
April 18, 2007 Hearing on Global Health
Judiciary Committee
June 6, 2007 Patent Reform: The Future of American Innovation
Committee on Health, Education, Labor, and Pensions
UNITAID Patent Pool for Medicines
In 2007 Medécins sans Frontières (MSF, Doctors Without Borders) and Knowledge Ecology International (KEI) presented a proposal for UNITAID to host a medicines patent pool.
In July 2008 the UNITAID Board supported the principle of establishing a patent pool for medicines to provide patients in low and middle income countries with increased access to more appropriate and lower price medicines.
Collective Management of IPR and Patent Pools
Submitted by Staff on 24. August 2009 - 11:30UNITAID patent pool for medicines
Cost Benefit Analysis for UNITAID Patent Pool
UNITAIDwebsite on patent pools
MSF website on patent pools
Biogenerics
Submitted by James Love on 17. August 2009 - 11:12James Love and James K. Glassman, Don’t Kill Competition for High-Tech Drugs, Roll Call, Sept. 9, 2009.
KEI Statement on Eshoo/Barton amendment
Some reporting
- James Love and James K. Glassman, Don’t Kill Competition for High-Tech Drugs, Roll Call, Sept. 9, 2009.
Recap on the House vote on Biosimilars
Submitted by James Love on 2. August 2009 - 13:56The rollcall for the biosimilars vote in on the Internet here. Based upon the count released by the committee, voting for the Eshoo Amendment were 26 Democrats and 21 Republicans. Voting against were 1 republican (Deal) and 10 Democrats. One Republican did not vote. I have bolded the Nay votes.
KEI statement on adoption of Eshoo/Barton amendment
Submitted by James Love on 31. July 2009 - 12:00In a roll call vote, the Eshoo/Barton amendment passed by a vote of 47 to 11. A number of consumer groups are issuing statements. This is the KEI statement on the vote.
James Love, Director Knowledge Ecology International (KEI),
(+1) (202) 361-3040, james.love@keionline.org
Howard Dean: “I’m actually not a shill for the bio industry”
Submitted by James Love on 21. July 2009 - 22:00The Center for American Progress hosted a video conference of Dr. Howard Dean talking about Health Care reform on Tueday. The video is on the web here. On this one hour program, Howard Dean spends a little over 3 minutes responding to allegations that he is a “shill” for BIO, on the issue of biosimilars.
